Further evidence of olfactory ensheathing glia facilitating axonal regeneration after a complete spinal cord transection by Ziegler, Matthias D. et al.
Further evidence of olfactory ensheathing glia facilitating axonal
regeneration after a complete spinal cord transection
Matthias D. Zieglera, Derek Hsua, Aya Takeokaa, Hui Zhonga, Almudena Ramón-Cuetod,
Patricia E. Phelpsa,c, Roland R. Roya,c, and V. Reggie Edgertona,b,c,*
aDepartment of Integrative Biology and Physiology, University of California, Los Angeles, Los
Angeles, CA 90095, USA
bDepartment of Neurobiology, University of California, Los Angeles, Los Angeles, CA 90095, USA
cDepartment of Brain Research Institute, University of California, Los Angeles, Los Angeles, CA
90095, USA
dInstitute of Biomedicine, CSIC, Valencia, Spain
Abstract
Spinal Wistar Hannover rats injected with olfactory ensheathing glia (OEG) have been shown to
recover some bipedal stepping and climbing abilities. Given the intrinsic ability of the spinal cord
to regain stepping with pharmacological agents or epidural stimulation after a complete mid-
thoracic transection, we asked if functional recovery after OEG injections is due to changes in the
caudal stump or facilitation of functional regeneration of axons across the transection site. OEG
were injected rostral and caudal to the transection site immediately after transection. Robotically
assisted step training in the presence of intrathecal injections of a 5-HT2A receptor agonist
(quipazine) was used to facilitate recovery of stepping. Bipedal stepping as well as climbing
abilities were tested over a 6-month period post-transection to determine any improvement in
hindlimb functional due to OEG injections and/or step training. The ability for OEG to facilitate
regeneration was analyzed electrophysiologically by transcranially stimulating the brainstem and
recording motor evoked potentials (MEP) with chronically implanted intramuscular EMG
electrodes in the soleus and tibalis anterior with and without intrathecal injections of
noradrenergic, serotonergic, and glycinergic receptor antagonists. Analyses confirmed that along
with improved stepping ability and increased use of the hindlimbs during climbing, only OEG rats
showed recovery of MEP. In addition the MEP signals were eliminated after a re-transection of the
spinal cord rostral to the original transection and were modified in the presence of receptor
antagonists. These data indicate that improved hindlimb function after a complete transection was
coupled with OEG-facilitated functional regeneration of axons.
Introduction
While the results of studies on the effects of olfactory ensheathing glia (OEG) in repairing
an injured spinal cord have been highly variable, so have the experimental paradigms used
to determine the reparative potential of these cells, differing in the type and severity of
injury, mixture of cell types, duration of transplant, transplantation procedures, and
parameters used to define regeneration (Frannsen et al., 2007). One of the more important
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questions yet to be answered conclusively is whether OEG can facilitate regeneration of
axons after a complete spinal cord transection. We therefore hypothesized that OEG
implanted immediately after a complete spinal cord transection can restore functional
connections between the rostral and caudal spinal cord stumps. Previous studies showed
improvement in hindlimb function in OEG spinal rats, but it is unclear whether this
improvement was attributable to regeneration of axons and/or to reorganization of the
neurons in the caudal stump (Ramón-Cueto et al., 2000, Lu et al., 2002; Keyvan-Fouladi et
al., 2003; Verdú et al., 2003; García-Alías et al., 2004; Polentes et al., 2004; López-Vales et
al., 2007; Kubasak et al., 2008). Some anatomical data are consistent with the presence of
regeneration, but these data are not conclusive (Ramón-Cueto et al., 2000; Takeoka et al.,
2009, 2010). In the present study we focused on a battery of functional (behavioral,
electrophysiological, and pharmacological) assessments during 6 months post-transection
and OEG injections, some of which were performed before and after re-transection of the
spinal cord.
We observed motor-evoked potentials (MEP) only in OEG rats. These MEP were modified
by step training and their amplitudes could be modulated by yohimbine, a NA receptor
antagonist, cyproheptadine, a 5-HT2 receptor antagonist, and/or strychnine, a glycinergic
receptor antagonist. In addition, the MEP were eliminated when the spinal cord was re-
transected rostral to the original transection site.
Methods
Experimental design
Spinal cord transection—All procedures were approved by the Chancellor's Animal
Research Committee at the University of California, Los Angeles and followed the
American Physiological Society Animal Care Guidelines. All surgical procedures were
performed under aseptic conditions with the rats deeply anesthetized using isoflurane gas via
facemask as needed. The spinal cords of 42 Wistar Hannover rats, 10–12 week old, were
transected completely at spinal cord level T8–T9 as previously described (Kubasak et al.,
2008). The paravertebral muscles were retracted, a partial laminectomy of the T8 and T9
vertebrae was performed, and the dorsal dura was opened with an ‘H’ cut to expose the
spinal cord. The spinal cord then was completely transected with micro-scissors. Two
surgeons independently verified a complete transection by passing a glass probe through the
site and lifting both cut ends of the spinal cord. The paravertebral muscles and fascia were
sutured using 4-0 chromic gut and the skin incisions closed with 4-0 Ethilon suture.
After surgery the rats were placed in an incubator maintained at 37 °C until fully recovered.
The rats were given lactated Ringers (5 cc, s.c.) to prevent dehydration. Baytril (5 mg/kg,
s.c., b.i.d., enrofloxacin, Bayer HealthCare LLC), a general antibiotic, and buprenex (0.05
mg/kg, s.c., b.i.d., buprenorphine hydrochloride, Reckitt Benckiser Healthcare (UK)
Limited), an analgesic, were administered during the first two days post-surgery. Manual
bladder expressions were performed three times per day for the first two weeks and then
twice daily, at 12 h intervals, thereafter. Rats were housed individually in polycarbonate
cages in a room maintained at 26 ± 1 °C with 40% humidity and a 12:12 h light:dark cycle.
Dry kibble and water were provided ad libitum and pieces of fruit were given daily.
OEG harvesting and injections—OEG were obtained from olfactory bulbs of Wistar
Hannover rats, 8–12 weeks old, and were immunopurified with the p75-receptor antibody.
Cells were re-suspended at a concentration of 100,000 cells per µl of serum-free Dulbecco's
Modified Eagle's Medium. Media with OEG (22 rats) or without OEG (20 rats) were
injected into the spinal cord, 1 mm rostral and caudal to the transection site. Four injections
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of ~50,000 cells were made into each stump. These procedures were described in Ramón-
Cueto et al. (2000) and Muñoz-Quiles et al. (2009).
Animal groups—Forty-two rats were separated into the following groups: Media
untrained (n = 10), Media trained (n = 10), OEG untrained (n = 11) and OEG trained (n =
11). Six rats from each of the untrained groups were used to test climbing ability. Responses
to brainstem stimulation were recorded from two intact rats implanted with intramuscular
EMG electrodes (see below).
Intramuscular EMG implantation procedures—Three months post-transection
intramuscular EMG electrodes were implanted in the soleus (an ankle extensor) and tibialis
anterior (TA, an ankle flexor) muscles bilaterally. A skin incision was made along the
sagittal suture of the skull and the muscles and connective tissues covering the skull were
reflected laterally. The skull was thoroughly dried and three stainless steel screws were
firmly inserted into the exposed bone. An Omnetics connector was placed between the
screws and rigidly affixed to the bone using dental cement. Multistranded, Teflon-coated
stainless steel wires (AS632, Cooner Electronics) connected to gold-plated pins in the head
connector were passed subcutaneously to the lower legs. Pairs of wires were passed into
each muscle belly using a 23-gauge needle and a small notch (~0.5–1.0 mm) was made in
the Teflon coating to make the electrodes. The electrodes were positioned in the mid-belly
of each muscle. Each muscle was stimulated through the head connector to assure proper
placement of the electrodes. The electrode wires then were anchored at both ends with 4.0
Ethilon suture. All exposed areas were kept moist with 0.9% saline washes. After
implantation, the muscles, fascia, and skin were sutured in layers.
Intrathecal catheter implantation procedures—During the same surgery as the EMG
electrode implantation, all rats were implanted with intrathecal catheters. A length of
polyurethane tubing (PE-10) was passed through a plastic head connector that was placed
between two screws inserted into the exposed skull. A 4 cm length of tubing was left at the
proximal end to be used for the injections. The distal end of the tubing had a tip made of
flexible silastic tubing to avoid damaging the spinal cord and was passed subcutaneously to
the back incision. A partial laminectomy was performed at vertebral level T11, and the
silastic tip carefully placed in the subarachnoid space and then tunneled to spinal level L2–
L3. The catheter was secured with suture at its entrance into the vertebral column. The
exposed tubing at the proximal end was sealed with a metal plug to prevent contamination.
The tubing was flushed with sterile saline 3 times per week with a volume of saline equal to
the length of the tubing. Before each flushing or injection of specific agents (see below), the
exterior tubing was wiped with 70% alcohol.
Kinematics training/testing
Step training and testing—The rats were trained with an assist-as-needed robotic step
training system (Fig. 1A), in which their ankles are attached to a robotic arm that provides
forces according to a programmed algorithm (Cai et al. 2006; Ziegler et al. 2010). The rats
were trained three days a week for 20 min per day using the assist-as-needed training
paradigm in combination with injections of quipazine (see below), a 5-HT2a receptor
agonist. Rats from both the trained and untrained groups were tested monthly for their
stepping ability while supporting ~20% of their body weight at a treadmill speed of 13.5 cm/
s without any assistance from the robotic system. Training and testing during the third and
fourth months were interrupted by the implantation of the EMG recording electrodes and
intrathecal catheters. Due to the time needed to recover from surgery, the rats were tested
once during either the third or fourth month of training. The rats were tested for their
stepping ability initially without and then with quipazine injections (intraperitoneally or
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intrathecally, see below) during each testing session. Reflective markers were attached to the
hindlimbs during testing and the stepping performance was recorded using four high-speed
cameras as described by Kubasak et al. (2008). The markers were analyzed using
KinemaTracer (Kissei Comtec). Principal Component Analysis (PCA) was used to
determine the consistency of the step trajectories as described by Fong et al. (2005).
Grid climbing test—A climbing grid was used to mimic previous tests that reported
increased hindlimb activity during climbing in OEG-compared to Media-injected spinal rats
(Ramón-Cueto et al., 2000). The grid was made to match the specifications used by Ramón-
Cueto et al. (2000). The ability of the rats to climb the grid at 45°, 60°, and 90° inclines was
determined (Fig. 1B). Once per week the rats (6 Media untrained and 6 OEG untrained rats)
were placed on the grid at each incline to acclimate them to the climbing apparatus. Their
ability to climb was tested at 6 months post-transection. During testing the rats were placed
at the bottom of the grid at each degree of incline and were left untouched until they reached
the top. Chocolate covered Fruit Loops were placed near the top of the grid to entice the rats
to climb. EMG activity was recorded during the climbing tests and the hindlimbs were
videotaped to assess the extent of their use during climbing. The video was marked for a
“pushoff” and the EMG assessed when a hindpaw was placed on a grid crossbar and the
ankle joint extended as the paw lifted off the crossbar and then placed on another crossbar
(see Supplemental Videos 1 and 2 for example of “pushoffs”).
Quipazine administration—Prior to implantation of the intrathecal tube, quipazine was
injected ~15 min before training intraperitoneally at a dosage of 0.5 mg/kg (Fong et al.,
2005; Ziegler et al., 2010). After the intrathecal tube was implanted the quipazine was
administered intrathecally at a dosage of 0.05 mg/kg ~5 min before testing (de Leon and
Acosta, 2006). A volume of ~20 µL of quipazine solution (diluted in sterile water at 1 mg/
mL) was injected into the intrathecal tube followed by injection of 20 µL of sterile saline.
Because it is known that 5-HT1a and 5-HT7 receptors are also important for stepping,
kinematics testing was examined using a combination of 8-hydroxy-2-(di-n-propylamino)
tertaline (8-OH-DPAT), a 5-HT1a,7 agonist, at a concentration of 0.03 mg/kg and quipazine
at a dosage of 0.03 mg/kg injected intrathecally. We were able to successfully record
stepping from 7 rats with this combination: however, 3 of the 7 rats died within two days of
the intrathecal injections and therefore we did not continue with this drug combination.
PCA analyses—Improvements in stepping consistency were characterized by measuring
the consistency of the repetition of a nominal trajectory. Step trajectories were separated into
horizontal and vertical components. Each step was normalized to the same number of data
points and the principal components were computed. The first principal component was used
as the “nominal” trajectory from the data set. The resulting PCA corresponded to the
consistency of stepping with higher PCA percentages reflecting more consistent and
therefore better stepping. The rat had to take at least 3 steps during testing to calculate the
PCA percentage. A score of 45% was assigned to any rat that took less than 3 steps (Cai et
al., 2006).
Normalized EMG data—MEP responses were normalized to the mean maximum EMG
burst amplitude for each muscle during stepping with quipazine. The mean maximum
amplitude of a minimum of 30 bursts for each muscle was determined. We then compared
the normalized amplitudes between rats. The normalized MEP was obtained using the
following equation: ((MEP Amplitude (mV)/Max EMG during stepping (mV) × 100) the
result then was multiplied by 100 to obtain the normalized percentage of the maximum
amplitude during stepping.
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Electrophysiological determinations
Pre-transection recordings—Recordings from two intact rats with EMG implants were
used for a MEP baseline reading. The rat was anesthetized lightly with 0.7%–2% isoflurane
and placed in a hammock to support its body while allowing its legs and arms to be
unrestrained. Two stimulating electrodes were placed subcutaneously over the brainstem.
The rats were stimulated using a single stimulus of 100 µs at a range of 75 mA to 200 mA
increased incrementally by 25 mA, equivalent to 2.5 mC per stimulus. The rats were given
at least 25 stimulations per session with at least 30 s of rest between stimulations. A constant
current stimulator (model DS7AH; Hertfordshire, England) was used to produce the
stimulations.
Post-transection recordings—Approximately one month after the transection surgery
the rats were tested electrophysiologically confirming a complete transection. For the first
month post-transection muscle activity was recorded using acutely implanted bilateral
subcutaneous electrodes placed over the medial gastrocnemius and TA muscles as
previously reported (Takeoka et al., 2008). To enhance the accuracy of the recordings
chronically implanted EMG electrodes were used thereafter (see below). Two rats showed a
MEP in all 4 muscles with brainstem stimulation during the 1 month post-transection test
and were eliminated from the study.
At four and six months post-transection, i.e., after the chronic intramuscular EMG electrodes
were implanted, the rats were tested again for the presence of MEP. After the six-month test
the rats were injected intrathecally with each of the following: cyproheptadine (a 5-HT2
receptor antagonist), yohimbine (a NA2 receptor antagonist), and strychnine (a glycine
receptor antagonist). Each injection was separated by a minimum of 24 h and tested on 7
OEG and 8 Media rats, with the exception of cyproheptadine where 5 OEG and 8 Media rats
were tested. Modulation of the MEP by these agents was analyzed to determine the role of
specific neurotransmitters in the recovery of MEP in OEG rats. Eight OEG and 5 Media rats
were re-transected 0.5 cm rostral to the original transection site and retested for the presence
of MEP immediately afterward.
Criteria for MEP—After each brainstem stimulation EMG recordings from the soleus and
TA were recorded for 1 s to identify any MEP responses. A response was considered to be a
MEP if it occurred less than 50 ms after the stimulation and was two standard deviations
above the signal noise. The window of 50 ms was used to allow for delays in signaling that
may occur after regeneration of neurons. The delay in the response of a regenerated neuron
was unknown. Therefore a window large enough to record any possible signal that was
recovered, including the possibility of a multi-synaptic signal and signals from unmyelinated
fibers, was used. If more than one peak occurred, the largest amplitude was used to measure
latency.
Statistical analyses
Kinematics and EMG data are reported as mean ± SEM. One-way ANOVA was used to
determine overall differences in training status, EMG, MEP, and response to
pharmacological interventions. Two-way ANOVA was used to determine overall
differences between Media and OEG trained and untrained groups followed by Tukey post-
hoc tests to make comparisons among groups. Pearson's correlation was used to determine
the linear relationship between selected variables. A p value less than 0.05 was used to
define statistical significance.
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Results
Step training and pharmacologically induced improvements in stepping ability in Media
rats
Stick diagrams and trajectories for a single step of a rat representing the untrained and
trained Media groups with and without injections of 5-HT receptor agonists are shown in
Figs. 2A and B, respectively. The EMG activity of the soleus and TA muscles corresponding
to these rats for single and a mean of 10 steps are shown in Figs. 2C and D, respectively.
These data show that the reciprocal activity between the TA and soleus was clearer in the
trained than untrained groups and clearest in the group receiving all three interventions.
Spinal rats with no interventions had a mean of 0.4 plantar placements (±0.4 SEM) during
the 20-s test (Fig. 2E). There was a progressive and significant increase in the mean number
of plantar placements made with the addition of each intervention, i.e., 25.5 ± 2.1, 32.6 ±
4.9, and 47.2 ± 3.6 plantar placements with quipazine alone, quipazine plus step training,
and quipazine plus step training plus 8-OH-DPAT, respectively.
The PCA analyses showed a similar trend (Fig. 2F), i.e., rats receiving no interventions did
not generate enough steps to be analyzed and received the lowest possible score of 45%,
whereas rats receiving quipazine alone, quipazine plus step training, and quipazine plus step
training plus 8-OH-DPAT had scores of 71.9 ± 2.9%, 77.7 ± 2.2%, and 85.9 ± 2.8%,
respectively. Mean step height was higher in rats treated with quipazine alone (26.9 ± 2.3
mm) or with all three interventions (30.5 ± 2.7 mm) than when step trained and treated with
quipazine (19.2 ± 1.8 mm) (Fig. 2G). Mean step length was longer in the rats treated with all
three interventions (37.5 ± 3.4 mm) than when treated with quipazine alone (26.7 ± 2.4 mm).
The mean percent of co-activation between the soleus and TA muscles was higher in rats
receiving quipazine alone (25.1 ± 3.4%) than in either group of step trained rats (11.8 ± 3.4
and 9.7 ± 2.4% co-activation for the quipazine plus step training and quipazine plus step
training plus 8-OH-DPAT groups, respectively) (Fig. 2H). The fact that there is co-
activation when the EMG is averaged over multiple steps (Fig. 2D) shows that there is
inconsistent timing of muscle bursting between steps.
Stepping ability is greater in OEG than Media rats
Media and OEG rats were tested monthly for their ability to step on a treadmill at a speed of
13.5 cm/s while supporting ~20% of their body weight. A stick diagram of a typical step and
the EMG response of the soleus and TA from a representative rat in the Media untrained,
OEG untrained, and OEG trained groups at the 4-month time point are shown in Figs. 3A, B
and D. For the Media trained group which did not step after EMG electrode implantation,
however, an example of a stick diagram of a typical step from the second month with no
EMG (prior to the EMG implants) is shown in Fig. 3C. The mean number of plantar
placements Fig. 3E) generated during each 20-s session throughout the 6-month period and
the step consistency as reflected by the PCA percentage averaged over all testing sessions
(Fig. 3F) were higher for the OEG trained than for either group of Media rats. Mean step
height was higher and step length longer in Media trained rats than in the Media untrained
group and higher in OEG trained than OEG untrained groups (Fig. 3G). For the OEG or
Media rats there was no training effect on the number of rats that stepped (data not shown)
or on the mean number of plantar placements (Fig. 3E). Therefore, the untrained and trained
groups were combined for the OEG and for the Media rats when comparing results over the
entire course of the experiment. The number of rats that performed plantar placements was
somewhat higher in the OEG than Media groups at all time points except 6 months post-
transection, although there was a statistical difference only at the second month time point
(Fig. 3H). There were more plantar placements generated in OEG than Media rats at 2 and
3/4 months post-transection (Fig. 3I). The level of co-activation between the soleus and TA
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was similar among the three groups that stepped successfully on the treadmill after the EMG
electrodes were implanted (Fig. 3J).
Stepping ability improved after quipazine treatment with training and/or OEG
transplantation
In the presence of quipazine, the consistency of the x–y trajectory during stepping (PCA)
and the number of plantar placements was improved by training in both the Media and OEG
groups compared to the Media untrained group (Figs. 4A and B). The OEG untrained rats,
however, were not different from any other group.
Increased hindlimb usage during climbing after OEG transplantation
All rats were able to climb at a 45°, 60°, and 90° inclines 6 months post-transection.
Although the level of success was similar among groups, the number of times the hindlimbs
of each rat were used to push off the apparatus was higher in the OEG than Media groups at
all inclines, except 90° (Fig. 5A). Overall during the climbing test the OEG and Media rats
used their hindlimbs an average of 19.8 and 2.5 times, respectively. During climbing the
mean EMG burst amplitudes of both the soleus and TA muscles were higher in the OEG
than Media rats (Fig. 5B). In addition, the mean EMG amplitude of the soleus was higher in
OEG rats when the leg was pushing off the crossbars of the climbing apparatus versus the
spontaneous bursting at all other times during climbing.
Time course of recovery of MEP after a complete spinal cord transection
The MEP response to subcutaneous brainstem stimulation was determined in two intact rats
implanted with EMG recording electrodes (Fig. 6A and Table 1). After the spinal cord
transection rats were tested with bilateral transcranial stimulation over the brainstem 1
month post-transection to confirm a complete transection of the spinal cord. Two rats
showed a response and were eliminated from the study. All other spinal rats showed no
response to the stimulation (Fig. 6B). During all subsequent tests there was no recovery of a
signal in the Media rats (Fig. 6E and Table 1). At 4 months post-transection we recorded
from chronically implanted intramuscular EMG electrodes and 7/20 OEG rats had a MEP in
one or both of the TA and soleus muscles (Table 1). Of the 7 rats that had a MEP response,
one was an untrained and 6 were trained OEG rats. At 6 months post-transection 13/18 OEG
rats had a MEP (Figs. 6C–E; Table 1). All muscles that that had a MEP response at 4
months also had a response at 6 months. Of the 13 rats that had a MEP response at 6 months
post-transection, 4 were untrained and 9 were trained OEG rats. The mean amplitude was
lower and the mean latency longer for the MEP in both trained and untrained OEG
compared to intact rats in both muscles and at both time points. At 6 months post-
transection, the mean MEP amplitude was higher and the mean latency shorter in both the
TA and soleus of the trained than untrained rats (Table 1). Furthermore, the mean MEP
amplitude of the TA was higher than in the intact and untrained rats at the 6-month time
point. When the spinal cord of 7 of the 13 OEG rats showing a MEP at 6 months were tested
immediately after re-transection, no MEP was observed (Fig. 6F).
To determine if there were any functional benefits associated with the recovery of MEP in
the OEG rats, we plotted the normalized amplitude of the MEP in each muscle of OEG
untrained rats against climbing ability (Figs. 7A and B) and OEG trained and untrained rats
against stepping ability (Figs. 7C and D). There was a significant positive correlation
between climbing ability and the MEP amplitude in the soleus (r = 0.65), but not the TA (r =
0.53). No relationship was observed between stepping ability and MEP amplitude in either
muscle (Figs. 7C and D). When training status was considered, the MEP amplitude was
higher (Fig. 7E) and the latency shorter (Fig. 7F) in the OEG trained than OEG untrained
Ziegler et al. Page 7
Exp Neurol. Author manuscript; available in PMC 2011 May 3.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
rats. Training status had no effect on the incidence of the MEP response to brainstem
stimulation (Fig. 7G).
Effects of receptor modulation on MEP
Compared to pre-drug administration, OEG rats showed a consistent and similar decrease in
MEP amplitude and response incidence in both the soleus and TA muscles after injection of
yohimbine (Fig. 8A). In addition, the MEP responses were similar in the trained and
untrained groups (Fig. 8B). In contrast, the MEP did not significantly change in any muscles
between pre- and post-drug administration when the same OEG rats were injected with
either cyproheptadine (Fig. 9A) or strychnine (Fig. 10A), except for a longer latency in the
TA after strychnine injection. When training status was considered, MEP amplitude in OEG
untrained rats was higher post-than pre-drug injection for both cyproheptadine (Fig. 9B) and
strychnine (Fig. 10B), whereas MEP amplitude was lower in trained OEG rats post- than
pre-cyproheptadine injection. Mean MEP latency in trained OEG rats was shorter post- than
pre-cyproheptadine injection (Fig. 9B), and longer in both groups after injection of
strychnine (Fig. 9B). In addition there was a significant difference in the MEP amplitude
between the trained and untrained groups after strychnine injection (Fig. 10B). When these
changes were plotted against stepping and climbing performance, no significant correlations
were found (data not shown).
Discussion
In the present study we show that in addition to improved hindlimb function, injection of
OEG facilitated regeneration of axons across a complete mid-thoracic spinal cord
transection. More specifically as in previous studies, we observed that OEG spinal rats had a
better climbing performance than Media rats 6 months after injection of OEG (Ramón-
Cueto et al. 2000; Muñoz-Quiles et al., 2009). TA and soleus EMG activity in OEG rats was
higher than in Media rats, particularly in the soleus when the hindlimb pushed off the grid
while climbing. Furthermore, the normalized MEP amplitude in the soleus correlated
directly with hindlimb usage during climbing. We also observed improved plantar
placement during stepping in OEG rats similar to Takeoka et al. (2008), although the
stepping ability was not correlated with the MEP responses. Stepping performance peaked
between the second and fourth months post-transection, whereas the incidence of
electrophysiological responses increased throughout the six months of testing.
We observed MEP post-transection only in OEG rats, a finding consistent with Takeoka et
al. (2008). The MEP had significantly lower amplitudes and longer latencies compared to
recordings in intact rats, also consistent with MEP recordings using subcutaneous acute
electrodes reported by Takeoka et al. (2008). These findings suggest that although multi-
synaptic pathways had developed, the degree of re-connectivity of the descending neuronal
pathways was small relative to these pathways in intact rats. To verify that these signals
were the result of re-connectivity across the lesion site, the spinal cord was re-transected
rostral to the original transection site. This eliminated all MEP in each of the OEG rats
tested whereas there were no changes detected in the Media rats.
Intrathecal injections of selected pharmacological antagonists allowed us to assess whether
there were NA, 5-HT, or glycinergic components to the supraspinal-muscle connections that
were re-established. In all spinal rats that showed a MEP there was a lower amplitude and
incidence of the signal after injection of yohimbine, a NA receptor antagonist. Previous
studies reported that intrathecal injections of yohimbine can decrease the stepping ability of
intact rats or rats having an incomplete spinal injury, but no effect on stepping after a
complete transection was reported even though NA receptors were present (Giroux et al.,
2001). The decreased response in amplitude and incidence of MEP is consistent with there
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being a NA receptor excitatory component to at least some of the re-established connections.
This modulation could have occurred over a single or multiple points along the brainstem-
muscle pathways. Given the wide distribution of the pharmacological effects on many
different types of cells (Hochman et al., 2001) it seems likely that some of this modulation
occurred pre-synaptically to the motoneurons as opposed to only a modulation of the
electrophysiological membrane properties of the motoneurons.
Step training significantly improved stepping in OEG rats, and the OEG trained rats also had
higher normalized MEP amplitudes than OEG untrained rats. While stepping improved in all
rats (Media and OEG) after intrathecal injections of quipazine, a 5-HT2A receptor agonist,
the stepping was further enhanced by assist-as-needed robotic training and even more so by
injections of a 5-HT1A,7 receptor agonist, 8-OH-DPAT. We observed previously that robotic
step training in combination with quipazine up-regulates 5-HT2A receptors in spinal mice
(Otoshi, 2008) and this may have contributed to the greater improvement of OEG trained
rats in the presence of quipazine.
Further evidence of a 5-HT component of the training effect in OEG rats is suggested by the
5-HT blocking experiments. For example, there were training dependent effects of
cyproheptadine on the MEP amplitude and latency, with both measures being lower in the
trained than untrained OEG rats after blocking with cyproheptadine. This is consistent with
the reported up-regulation of 5-HT2A receptors after robotically assisted training in the
presence of quipazine (Otoshi, 2008).
Strychnine, a glycinergic antagonist, increased the amplitude of the MEP of the untrained
rats. These results are consistent with the reported marked improvement in stepping of
complete spinal cats that had little or no stepping ability, while strychnine had little effect on
trained cats and rats that could already step (de Leon et al, 1999; unpublished observations).
These contrasting results probably reflect the up-regulation of glycinergic receptors that
occurs after a complete spinal lesion, an elevation of the chloride equilibrium potential
(Boulenguez et al., 2010; Edgerton and Roy, 2010), and/or the fact that this up-regulation
returns toward normal levels with step training.
The pharmacological experiments reflected in the multiple parameters measured and the
multiple mechanisms through which the pharmacological antagonists could have affected
the total circuitry are complex. The general conclusion is that there were functional
reconnections, i.e., synapses capable of generating electrical potentials, formed only in OEG
rats. Based on the relatively long latencies observed, most, if not all of these brain-to-muscle
connections were most likely multi-synaptic. With one exception, i.e., the latency after the
injection of strychnine, this re-connectivity was similar in circuits projecting to a flexor and
an extensor motor pool. Finally there was evidence that step training influenced the
formation of these re-connections having a 5-HT2 or glycinergic, but not a NA2, component.
But the over-riding conclusion of most importance is that among these newly formed
connections, there were multiple observations strongly suggesting that there were
neurotransmitter components involving NA2, 5-HT2, and glycinergic receptors among the
new supraspinal-muscle connections made and that this occurred exclusively in OEG rats.
The effects of each receptor antagonist on the MEP amplitude, reflecting the strength of the
signal (relative number of excitatory vs. inhibitory synapses activated), after each
experiment are shown in Fig. 11. Although only MEP amplitudes are illustrated in Fig. 11
significant differences also were observed in the latency, reflecting the predominant number
of synapses placed “in series”, and the incidence of MEP, reflecting the robustness
(consistency) of the signal (Figs. 8–11).
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We have shown evidence of functional axonal connections across a complete spinal cord
transection in OEG spinal rats. The effects of these regenerated axons on the recovery of
stepping ability, however, appear to be inconsistent, i.e., the stepping performance was
enhanced in some rats but either not affected or suppressed in others. In fact, there was no
correlation between the recovery of MEP and the number of steps performed during the
monthly testing. In contrast there was a strong correlation between the MEP amplitude and
hindlimb activity during climbing. The improved hindlimb function during climbing versus
the limited and inconsistent improvement in stepping in rats demonstrating MEP may be
related to the nature of the tasks. Perhaps climbing requires more involvement of supraspinal
control compared to the more automatic movements for stepping. The influence of
regenerated axons on bipedal stepping was not significant and, in fact, seems to have caused
variable responses in different rats. Some rats had improved stepping while others showed
no change. In effect, it appears that there were behavioral effects of OEG and training on the
lumbosacral locomotor circuitry as well as in facilitating regeneration and influencing the
newly re-established supraspinal-spinal reorganization that seems to occur once new
connections are made.
The present data show that the OEG facilitated axon regeneration involves one or more
neurotransmitter systems. Furthermore, step training appears to increase the magnitude of
the MEP in the presence of OEG. Overall, this regeneration was a positive factor in
improving function of the hindlimbs during a climbing task, but was not correlated with
hindlimb stepping. While the mechanisms of the newly regenerated, functional connections
established in a complete spinal adult rat are not yet understood, it is clear that OEG
transplantation facilitated axonal regeneration. Now the challenges are to determine how to
achieve more robust effects by increasing the number of connections and encourage a
functionally beneficial reorganization of the newly established connections between the
brain and the spinal cord circuitries.
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Fig. 1.
Stepping and climbing apparatus. A shows the robotically assisted step training method
(Ziegler et al., 2010). If the ankle of the rat is at a position within the open circle (marked by
the “X”) the robotic arms are passive and the leg is able to move freely in any direction
within that area (open arrows). When the ankle leaves the circle the robotic arms guide it
back into the open circle. The robotic arms also provide a small force guiding the ankle to
the next point (closed circle) in the programmed trajectory. The closed arrows show forces
that adjust the ankle position to this area which are proportional to the distance from the
desired position. B shows the apparatus used for the climb test (Ramón-Cueto et al., 2000).
A platform (50 cm × 30 cm) with a slippery surface was set up 70 cm from the floor and a
wire grid (2.5 cm grid holes) was set at three different inclines (45°, 60°, and 90°) during
testing.
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Fig. 2.
Improved stepping through training and 5-HT agonists for Media rats tested (20 s) after 4
months of training post-transection. Panels A–D show examples of different kinematics
aspects of stepping for Media rats under three conditions: after injections of quipazine alone
(+Q), left column; after step training (+T) plus injection of quipazine, center column; and
after step training plus quipazine plus 8-OH-DPAT (+8), right column. A shows a stick
figure diagram of a representative step under each condition, from markers at the iliac crest,
hip, knee, ankle, foot, and toe. The two examples from the trained groups are from the same
trained rat. B shows the average step trajectory, taken from all completed steps in one
session, for the rats shown in A. C shows the EMG activity in the soleus and TA muscles
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from a single plantar step and D shows the average EMG of 10 steps from the rats shown in
A–C. E shows the average number of plantar placements taken during 20 s of stepping by
each of the same three groups as above plus a Media group receiving no interventions. F
shows the average PCA analysis (see Methods) for the same groups as in E. G shows the
mean height and length of the step trajectory. H shows the average percent time co-
activation of the soleus and TA muscles. Bars in E–H are mean ± SEM for 10 rats/group,
except +Q, +T, and +8 which is a group of 7 rats. *, significant difference between groups at
p<0.05.
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Fig. 3.
Step kinematics of Media and OEG rats taken 6 months post-transection, unless otherwise
noted. A–D show a stick figure diagram of a typical step from a representative rat from each
group. Underneath each stick figure is the averaged raw EMG activity of the soleus and TA
during stepping for each rat for one testing session, except for the Media trained as no rat
from this group stepped in months four through six (N/A). E shows the average number of
plantar placements taken by the Media untrained (M-U), Media trained (M-T), OEG
untrained (O-U), and OEG trained (O-T) groups over the 6-month experimental period. F
shows the average PCA analysis for each group of rats over all testing sessions. G shows the
average height and length for all plantar placements taken by each group over all testing
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sessions. H shows the total number of OEG and Media rats that took plantar placement steps
each month. I shows the average number of plantar placements taken by OEG and Media
rats during each month. J shows the percent time of co-activation of the soleus and TA for
the averaged step EMG data shown in A, B, and D. Bars in E–G and J are mean ± SEM for
10 rats/group. Bars in I are ± SEM for 15–20 rats/group. *, significant difference between
groups at p<0.05.
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Fig. 4.
Stepping ability of Media and OEG rats with quipazine administration. A shows the PCA
analysis and B the number of plantar placement steps for each group for 20 s of stepping
after quipazine administration. Bars are mean ± SEM for 10 rats/group. Group
abbreviations, same as in Fig. 3. *, significant difference between groups at p<0.05.
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Fig. 5.
Hindlimb usage during climbing for Media untrained and OEG untrained rats A shows the
average number of times that each of the OEG or Media rats pushed off with their hindlimbs
during the climbing task. B shows the mean (±SEM) EMG amplitude of the TA and soleus
muscles in the OEG and Media groups for the pushoff and at all other times (spontaneous)
during the climbing task. All tests were done on 6 rats per group. *, significant difference
between OEG and Media groups at p<0.05. †, significant difference within the OEG group
at p<0.05.
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Fig. 6.
Examples of MEP at different time points during the experiment. A shows a MEP response
to brainstem stimulation for an intact rat. The recording saturated at 10 mV. Therefore a flat
portion of the signal appears if the values are higher than 10 mV. B is a MEP response for
an OEG trained rat 1 month post-transection. C is the recovered MEP in the OEG rat in B 6
months post-transection. D is a MEP response 6 months post-transection in an OEG
untrained rat. E shows the lack of any MEP response 6 months post-transection in a Media
rat. F shows the lack on a MEP response from the same rat in graphs B and C after re-
transection of the spinal cord at a level rostral to the initial transection. The scale bar in C is
the same for B–F.
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Fig. 7.
MEP amplitudes relative to hindlimb performance in trained and untrained OEG rats 6
months post-transection. A and B show the relationship between the number of times the
hindlimbs were used (pushing off) and the normalized MEP amplitude ((MEP Amplitude
(mV)/Max Stepping EMG (mV)) × 100)) in the soleus and TA muscles of untrained OEG
rats, respectively. Each dot represents the number of pushoffs for a single leg (2 dots per
rat). C and D show the relationship between the number of plantar placement steps taken by
each trained and untrained OEG rat and the normalized MEP amplitude of the soleus and
TA muscles, respectively. E–G show the differences in the normalized amplitude (E),
latency (F), and incidence (G) of the MEP response between OEG trained and untrained
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rats. The correlation plots are based on data from 6 OEG untrained rats (A and B) or 8 OEG
trained and 5 OEG untrained rats (C–D). Bar graphs in (E–G) are means ± SEM for 8 OEG
trained and 5 OEG untrained rats.*, significant difference between groups at p<0.05.
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Fig. 8.
MEP modulation due to yohimbine, a NA2 receptor antagonist. A and B show the MEP
response of all OEG rats after intrathecal injection of yohimbine. A shows the percent
change in MEP amplitude, latency, and incidence for each muscle post- compared to pre-
injection. B shows the percent change in MEP amplitude, latency, and incidence post-
compared to pre-injection in both muscles of OEG trained and untrained rats. Bars are mean
± SEM for 7 rats. #, significant difference between pre- and post-yohimbine injection at
p<0.05.
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Fig. 9.
MEP modulation due to cyproheptadine, a 5-HT2 receptor antagonist. A and B show the
MEP response of all OEG rats after intrathecal injection of cyproheptadine. A shows the
percent change in MEP amplitude, latency, and incidence for each muscle post- compared to
pre-injection. B shows the percent change in MEP amplitude, latency, and incidence post-
compared to pre-injection in both muscles of OEG trained and untrained rats. Bars are mean
± SEM for 5 rats. *, and # significant difference between groups and between pre-and post-
cyproheptadine injection, respectively, at p<0.05.
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Fig. 10.
MEP modulation due to strychnine, a glycinergic receptor antagonist. A and B show the
MEP response of all OEG rats after intrathecal injection of strychnine. A shows the percent
change in MEP amplitude, latency, and incidence for each muscle post- compared to pre-
injection. B shows the percent change in MEP amplitude, latency, and incidence post-
compared to pre-injection in both muscles of OEG trained and untrained rats. Bars are mean
± SEM for 7 rats. *, and #, significant difference between groups and between pre-and post-
strychnine injection, respectively, at p<0.05.
Ziegler et al. Page 25
Exp Neurol. Author manuscript; available in PMC 2011 May 3.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Fig. 11.
Graphic summary of the effects of each receptor antagonist on the amplitude of the MEP
response in untrained (UTr) and trained (Tr) OEG rats as shown in Figs. 8–10.
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